Exposição a Hidrocarbonetos policíclicos aromáticos (HPAs) está relacionada com o aumento de risco de câncer. Esses carcinógenos dependem da sua ativação para intermediários eletrofílicos para causar danos em biomoléculas. As vias de ativação melhor estudadas incluem (i) a formação de diol-epóxido nas regiões de baía ou fjord dos HPAs através de epoxidações catalisadas pela citocromo P450 (CYP450), com uma hidrólise intermediária pela epóxido hidrolase e (ii) oxidação (CYP450 ou peroxidases) levando à formação de um cátion radical reativo. Outras vias incluem a formação de derivados metilados, quinonas e metabólitos de anel aberto cujas contribuições para a carcinogênese ainda são pouco estudadas, assim como o papel do estresse oxidativo na toxicidade dos HPAs. Neste trabalho foi investigado a citotoxicidade e genotoxicidade do indeno[1,2,3-cd]pireno, trifenileno e coroneno e seus produtos de oxidação (quinonas e hidroquinonas). Linhagens de carcinoma hepatocelular humano (HepG2) e de hepatócitos humanos normais (THLE-2) foram incubadas com os HPAs e suas respectivas quinonas e hidroquinonas acetiladas para análise de viabilidade celular (MTT) em diferentes condições de cultivo (por 16 horas, de 20 a 200 uM). Células HepG2 foram incubadas por 16 horas com indeno[1,2,3-cd]pireno (50 µM), coroneno (20 µM), trifenileno (10 uM) ou seus produtos de oxidação (quinonas e hidroquinonas acetiladas) para análise de dano oxidativo em DNA e peroxidação lipídica. Nas concentrações descritas acima, esses HPAs estruturalmente diferentes e seus produtos de oxidação são citotóxicos e levam ao aumento dos níveis de 7,8- dihidro-8-oxo-2\'-desoxiguanosina e malonaldeído. Tais danos podem contribuir para o aumento do risco de desenvolvimento de doenças, como o câncer, na população exposta. / Exposure to Polycyclic Aromatic Hydrocarbons (PAH) is related to the increase in the risk of cancer. These carcinogens depend on their activation by electrophilic intermediates to cause damage on biomolecules. The best understood activation pathways include (i) the formation of diol-epoxide in the bay and fjord regions of the PAH through epoxidations catalyzed by cytochrome P450 (CYP450), with an intermediate hydrolysis by epoxide hydrolase and (ii) oxidation (CYP450 or peroxidases) leading to the formation of a reactive cationic radical. Other pathways include the formation of methylated derivatives, quinones and open-ring metabolites whose contributions to carcinogenesis, as well as the role of oxidative stress on PAH toxicity, have not been extensively studied yet. This work investigated the cytotoxicity and genotoxicity of indene[1,2,3-cd]pyrene, triphenylene and coronene and their oxidation products (quinones and hydroquinones). Strains of human hepatocellular carcinoma (HepG2) and of normal human hepatocytes (THLE-2) were incubated with PAH and their respective quinones and acetylated hydroquinones and afterwards analyzed for cell viability (MTT) under different culture conditions (for 16 hours, 20 to 200 BM). HepG2 cells were incubated for 16 hours with indene[1,2,3-cd]pyrene (50 BM), coronene (20 BM), triphenylene (10 BM) or their oxidation products (quinones and acetylated hydroquinones) and afterwards analyzed for oxidative damage on DNA and lipid peroxidation. In the mentioned concentrations, these structurally different PAHs and their oxidation products are cytotoxic and lead to an increase in the levels of 7,8-dihydro-8-oxo-2\'-deoxyguanosine and malonaldehyde. Such damages may contribute to increase the risk of diseases like cancer in the exposed population.

Traumatic brain injury (TBI) represents a significant health crisis. To date there are no FDA-approved pharmacotherapies available to prevent the neurologic deficits caused by TBI. Following TBI, dysfunctional mitochondria generate reactive oxygen and nitrogen species, initiating lipid peroxidation (LP) and the formation of LP-derived neurotoxic aldehydes, which bind mitochondrial proteins, exacerbating dysfunction and opening of the mitochondrial permeability pore (mPTP), resulting in extrusion of mitochondrial sequestered calcium into the cytosol, and initiating a downstream cascade of calpain activation, spectrin degradation, neurodegeneration and neurologic impairment. As central mediators of the TBI secondary injury cascade, mitochondria and LP-derived neurotoxic aldehydes make promising therapeutic targets. In fact, Cyclosporine A (CsA), an FDA-approved immunosuppressant capable of inhibiting mPTP has been shown to be neuroprotective in experimental TBI. Additionally, phenelzine (PZ), an FDA-approved non-selective irreversible monoamine oxidase inhibitor (MAOI) class antidepressant has also been shown to be neuroprotective in experimental TBI due to the presence of a hydrazine (-NH-NH2) moiety allowing for the scavenging of LP-derived neurotoxic aldehydes. The overall goal of this dissertation is to further examine the neuroprotective effects of the mPTP inhibitor, CsA, and the LP-derived neurotoxic aldehyde scavenger, PZ, using a severe controlled cortical impact injury (CCI) model in 3-month old male Sprague-Dawley rats. First, the effects of CsA on cortical synaptic and non-synaptic mitochondria, two heterogeneous populations, are examined. Our results indicate that compared to non-synaptic mitochondria, synaptic mitochondria sustain greater damage 24h following CCI and are protected to a greater degree by CsA. Second, the neuroprotective effects of a novel 72h continuous subcutaneous infusion of CsA combined with PZ are compared to monotherapy. Following CCI, our results indicate that individually both CsA and PZ attenuate modification of mitochondrial proteins by LP-derived neurotoxic aldehydes, PZ is able to maintain mitochondrial respiratory control ratio and cytoskeletal integrity, but together, PZ and CsA, are unable to improve and in some cases negate monotherapy neuroprotective effects. Finally, the effects of PZ (MAOI, aldehyde scavenger), pargyline (PG, MAOI, non-aldehyde scavenger) and hydralazine (HZ, non-MAOI, aldehyde scavenger) are compared. Our results indicate that PZ, PG, and HZ are unable to improve CCI-induced deficits to learning and memory as measured by Morris water maze (post-CCI D3-7). Of concern, PZ animals lost a significant amount of weight compared to all other group, possibly due to MAOI effects. In fact, in uninjured cortical tissue, PZ administration leads to a significant increase in norepinephrine and serotonin. Additionally, although PZ, PG, and HZ did not lead to a statistically significant improvement in cortical tissue sparing 8 days following CCI, the HZ group saw a 10% improvement over vehicle. Overall, these results indicate that pharmacotherapies which improve mitochondrial function and decrease lipid peroxidation should continue to be pursued as neuroprotective approaches to TBI. However, further pursuit of LP-derived aldehyde scavengers for clinical use in TBI may require the development of hydrazine (-NH-NH2)-compounds which lack additional confounding mechanisms of action.

Les acides gras polyinsaturés oméga-3 à longue chaîne (AGPIω3-LC), principalement représentés par l'acide eicosapentaénoïque (EPA) et l'acide docosahexaénoïque (DHA), présentent des effets bénéfiques vis-à-vis de l'athérosclérose. Leur action au niveau vasculaire est suggérée. Les mécanismes d'action sont mal compris du fait de la complexité d'action des AGPIω3-LC au niveau cellulaire. Les AGPIω3-LC affectent de nombreuses protéines y compris les facteurs de transcription, ce qui engendre la modulation de l'expression de nombreux gènes. La complexité s'accroît si l'on considère l'ensemble des métabolites oxygénés issus des AGPIω3-LC. Les métabolites issus de la peroxydation lipidique peuvent être produits en abondance au cours de l'athérogenèse mais leur bioactivité est quasiment inconnue. Des points majeurs restent à éclaircir comme l'identification des cibles cellulaires et moléculaires au niveau vasculaire et la bioactivité des métabolites peroxydés. Objectifs : étudier l'impact du DHA au niveau vasculaire et évaluer la bioactivité de certains métabolites issus de la peroxydation lipidique du DHA. Les travaux visant à étudier les propriétés athéro-protectrices du DHA n'ont jusqu'à présent pas permis d'obtenir une vision globale de son spectre d'action. La nutrigénomique a paru être une approche pertinente pour étudier les effets du DHA au niveau vasculaire. Une étude in vivo a été réalisée sur des souris athérosclérotiques LDLR-/- recevant ou non une supplémentation en DHA (2% de l'apport énergétique journalier). Le rôle athéro-protecteur du DHA a été confirmé dans une étude précédente rapportant une diminution de 35% de l'étendue des lésions au niveau aortique dans le groupe DHA. Au niveau protéique, nous avons montré une altération significative de l'expression de protéines intervenant principalement au niveau des métabolismes glucidique et lipidique mais aussi dans les défenses anti-oxydantes. Au niveau génique, la composante inflammatoire s'est avérée être une cible majeure du DHA au niveau vasculaire. La supplémentation en DHA a réduit l'expression de gènes impliqués dans l'adhésion cellulaire, la chimiotaxie et la présentation de l'antigène. Plusieurs gènes se sont avérés être des marqueurs phénotypiques des macrophages et l'analyse des régulateurs transcriptionnels montrait une implication probable de PPARγ, IFNγ et NFκB dans les modulations d'expression génique observées. Nos analyses suggèrent une orientation préférentielle des macrophages vers un phénotype réparateur de type M2 chez les souris recevant la supplémentation en DHA. Une analyse immunohistochimique au niveau aortique a révélé une plus grande abondance d'arginase I. Une approche plus ciblée alliant une étude in vitro sur un modèle de macrophages humains et l'utilisation de métabolites peroxydés spécifiques du DHA, les neuroprostanes, nous a permis de conforter notre hypothèse selon laquelle le DHA pourrait agir au moins en partie via ses métabolites peroxydés. L'exposition des macrophages à deux types de neuroprostanes (les 4-F4t et les 14-A4-Neuroprostanes) a permis de réduire significativement l'expression et la sécrétion de plusieurs médiateurs pro-inflammatoires. Des résultats préliminaires suggèrent que ces effets anti-inflammatoires des neuroprostanes seraient indépendants de PPARγ mais liés à une inhibition de la voie NFκB. L'étude in vivo et l'utilisation de la nutrigénomique nous ont permis d'explorer de façon ouverte et non biaisée l'impact du DHA au niveau vasculaire. Les résultats sont que le DHA active le métabolisme énergétique et les défenses anti-oxydantes et diminue l'état inflammatoire avec une implication probable du DHA dans l'orientation phénotypique des macrophages vers un phénotype réparateur de type M2. Les résultats obtenus in vitro sur macrophages primaires humains confirment que les métabolites peroxydés du DHA contribuent à ses propriétés anti-inflammatoires. / Numerous studies have reported beneficial effects of long chain omega-3 polyunsaturated fatty acids (LC-ω3PUFAs) on atherosclerosis and associated cardiovascular events. These fatty acids are mainly represented by eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA). LC-ω3PUFAs exert their athero-protective action mainly by a reduction of triglyceridemia, increased endothelial relaxation, and reduced inflammation. Their specific action at the vascular level is suggested. Their mechanisms of action are still only partially understood because of the complexity of action of LC-ω3PUFAs at the cellular level. LC-ω3PUFAs affect several membrane or cytosolic proteins, including transcription factors, which modulate numerous gene expression. The complexity is further increased when considering a wide range of oxygenated metabolites derived from LC-ω3PUFAs. Among them, the metabolites from lipid peroxidation may be produced in abundance during atherogenesis but their bioactivity is almost unknown. There are still major issues to be clarified, such as the identification of cellular and molecular targets at the vascular level ; the bioactivity of peroxidized metabolites that could play a key role in the prevention of atherosclerosis. The objective of this work was to study the impact of DHA at the vascular level and to evaluate the bioactivity of selected metabolites from DHA lipid peroxidation. Studies on anti-atherogenic properties of DHA have so far been carried out only in a targeted manner that does not provide a comprehensive and integrated view of its spectrum of action. Nutrigenomics appears to be a relevant approach to study the effects of DHA at the vascular level. In vivo study was performed on LDLR-/- atherosclerotic mice supplemented or not with DHA. The athero-protective effect of DHA has been confirmed in the previous study performed by our team reporting a 35% decrease of the atherosclerotic lesion in the DHA group. Aorta proteome study demonstrated a significant alteration of the expression of proteins involved mainly in the carbohydrate and lipid metabolism and also in antioxidant defenses. At the transcriptome level, the inflammatory component of atherosclerosis appears to be a major target of DHA at the vascular level. More precisely, DHA supplementation reduced the expression of genes involved in cell adhesion, chemotaxis and antigen presentation. Several genes were found to be phenotypic markers of macrophages and analysis of transcriptional regulators showed a possible contribution of PPARγ, IFNγ and NFκB to the observed modulation of gene expression. Our results suggest a preferential orientation of macrophages to a M2 type repair phenotype in mice receiving DHA supplementation. This was confirmed by immunohistochemical analysis at the aorta which revealed a greater abundance of arginase I. We chose a focused in vitro study of the action of specific DHA peroxidized metabolites: the neuroprostanes on a human macrophages. This study allowed us to confirm our hypothesis that DHA may act at least in part via its peroxidized metabolites. The macrophages exposition to 2 types of neuroprostanes (4-F4t and 14-A4-Neuroprostanes) has significantly reduced the expression and secretion of several pro-inflammatory mediators. Preliminary results suggest that these anti-inflammatory effects are PPARγ-independent but related to inhibition of NFκB pathway. In vivo study, and nutrigenomics approach, allowed us to explore the impact of DHA at the vascular level by an open and unbiased way. The results are that DHA activates energy metabolism and antioxidant defenses and reduces the inflammatory component of atherosclerosis with a possible involvement of DHA in the phenotypic direction of macrophages to a M2 type repair phenotype. The results obtained in vitro on primary human macrophages confirmed that DHA peroxidized metabolites contribute to its anti-inflammatory properties.

<p>Lipid peroxidation is thought to be an important factor in the pathophysiology of a number of diseases and in the process of ageing, but its measurement <i>in vivo</i> has been difficult. The aim of this thesis was to evaluate methods for measurement of lipid peroxidation <i>in vivo</i> that are suitable for clinical investigations, and to apply these methods in animal and human studies investigating basal conditions and situations associated with increased lipid peroxidation.</p><p>The ferrous oxidation in xylenol orange assay for quantification of total plasma lipid hydroperoxides was re-evaluated regarding sample handling and storage. It was shown to be a useful tool for analyses of fresh but not stored plasma samples.</p><p>A methodology for measurement of the total amount (sum of free and esterified) of an F₂-isoprostane, 8-iso-prostaglandin F_2α, in tissues using alkaline hydrolysis in combination with an existing radioimmunoassay was developed. High levels of 8-iso-prostaglandin F_2α in rat liver tissue were quantified by this technique both at basal conditions and in an experimental model of increased lipid peroxidation induced by carbon tetrachloride.</p><p>Supplementation with vitamin E to rats decreased both non-enzymatic and enzymatic lipid peroxidation as measured by 8-iso-prostaglandin F_2α and a major prostaglandin F_2α metabolite. This was verified both in the urine at basal conditions, and in the urine and liver tissue after carbon tetrachloride induced lipid peroxidation.</p><p>In a randomised cross-over study in humans, a rapeseed oil-based diet with an increased proportion of easily oxidised polyunsaturated fatty acids was compared to a control diet rich in saturated fats. The rapeseed oil-based diet did not seem to increase the degree of lipid peroxidation in plasma and urine as measured by 8-iso-prostaglandin F_2α, hydroperoxides and malondialdehyde, presumably due to a sufficient content of antioxidants in the rapeseed oil diet.</p><p>In conclusion, the simultaneous measurement of several biomarkers of lipid peroxidation is a promising approach for future studies investigating the possible role of lipid peroxidation <i>in vivo</i> under basal conditions and in the pathology of diseases.</p>

<p>Insulin sensitivity is related to the fatty acid profile of skeletal muscle. The aim of this thesis was to investigate whether physical activity and dietary fat quality, independent of each other, influence the fatty acid composition of the skeletal muscle lipids. In an intervention study where middle-aged men were exercising for six weeks, and in a cross-sectional study comparing sedentary with endurance trained young men, it was demonstrated that the fatty acid composition of skeletal muscle lipids differed between physical active and inactive men. In brief, a lower proportion of palmitic acid (16:0) and total n-6 polyunsaturated fatty acids (PUFA) and a higher proportion of stearic (18:0) and oleic acid (18:1n-9) and total n-3 PUFA in the muscle phospholipids were associated with physical activity, despite similar fatty acid composition of the diet. In the second study, that included a larger training volume, differences in the fatty acid profile were also found in the skeletal muscle triglycerides. </p><p>In contrast, after short-term supra-maximal exercise we found no significant changes in the proportion of the fatty acids in skeletal muscle. </p><p>Furthermore, after a treatment period of three months, with diets with various dietary fat quality, the proportions of saturated fatty acids (14:0, 15:0 and 17:0) were higher and the proportion of 18:1 n-9 lower in subjects with a high intake of saturated fatty acids compared with subjects with a high intake of monounsaturated fatty acids. In addition subjects given n-3 supplementation had a higher proportion of total n-3 PUFA and lower n-6 PUFA in the skeletal muscle phospholipids than controls. Differences similar to those observed in the phospholipids were found in the triglycerides. </p><p>In summary, these results suggest that regular aerobic physical activity and dietary fat quality influence the fatty acid composition of the skeletal muscle lipids, which may affect insulin sensitivity and glucose homeostasis. </p>

<p>Numerous diseases are associated with reduced antioxidant defence and oxidative stress. The antioxidant defence includes dietary and endogenous antioxidants and involves complex interactions between them. The effects of dietary factors on antioxidant status and oxidative stress of healthy humans were investigated in the studies described in this thesis. Assays of plasma antioxidant capacity encompass interactions between various antioxidants. Although uric acid has an unclear function as an antioxidant, it is a major determinant of antioxidant capacity. We measured antioxidant capacity in the presence and absence of uric acid to provide more information on the application of measures of antioxidant capacity. Individuals with high dietary intakes of various antioxidants and antioxidant rich foods, especially when combined, had higher plasma antioxidant capacities than those with lower antioxidant intakes. However, there were no associations between dietary intake of antioxidants or antioxidant rich foods and the plasma concentration of F₂-isoprostanes, which is considered a reliable biomarker for oxidative stress. Intakes of various doses of a mixture of bilberry juice and black tea, rich in flavonoids for four weeks, increased antioxidant capacity in some groups, but urine levels of F₂-isoprostanes were not affected. There were substantial individual variations in responses to the drinks related to baseline antioxidant capacity. Supplementation with eicosapentaenoic acid and docosahexaenoic acid decreased the plasma levels of F₂-isoprostanes, but not prostaglandin F_2α formation or antioxidant capacity. </p><p>It was concluded that a high intake of foods rich in antioxidants is related to improved antioxidant status. After intake of foods rich in antioxidants, the antioxidant status may increase, but with considerable individual variation in the responses, which warrants further investigation. Lipid peroxidation <i>in vivo</i> is not easily affected by dietary antioxidants in healthy humans. Although n-3 fatty acids are highly unsaturated, they reduce nonenzymatic free radical-catalyzed lipid peroxidation, but not enzymatic lipid peroxidation.</p>

Lipid peroxidation is thought to be an important factor in the pathophysiology of a number of diseases and in the process of ageing, but its measurement in vivo has been difficult. The aim of this thesis was to evaluate methods for measurement of lipid peroxidation in vivo that are suitable for clinical investigations, and to apply these methods in animal and human studies investigating basal conditions and situations associated with increased lipid peroxidation. The ferrous oxidation in xylenol orange assay for quantification of total plasma lipid hydroperoxides was re-evaluated regarding sample handling and storage. It was shown to be a useful tool for analyses of fresh but not stored plasma samples. A methodology for measurement of the total amount (sum of free and esterified) of an F2-isoprostane, 8-iso-prostaglandin F2α, in tissues using alkaline hydrolysis in combination with an existing radioimmunoassay was developed. High levels of 8-iso-prostaglandin F2α in rat liver tissue were quantified by this technique both at basal conditions and in an experimental model of increased lipid peroxidation induced by carbon tetrachloride. Supplementation with vitamin E to rats decreased both non-enzymatic and enzymatic lipid peroxidation as measured by 8-iso-prostaglandin F2α and a major prostaglandin F2α metabolite. This was verified both in the urine at basal conditions, and in the urine and liver tissue after carbon tetrachloride induced lipid peroxidation. In a randomised cross-over study in humans, a rapeseed oil-based diet with an increased proportion of easily oxidised polyunsaturated fatty acids was compared to a control diet rich in saturated fats. The rapeseed oil-based diet did not seem to increase the degree of lipid peroxidation in plasma and urine as measured by 8-iso-prostaglandin F2α, hydroperoxides and malondialdehyde, presumably due to a sufficient content of antioxidants in the rapeseed oil diet. In conclusion, the simultaneous measurement of several biomarkers of lipid peroxidation is a promising approach for future studies investigating the possible role of lipid peroxidation in vivo under basal conditions and in the pathology of diseases.

Insulin sensitivity is related to the fatty acid profile of skeletal muscle. The aim of this thesis was to investigate whether physical activity and dietary fat quality, independent of each other, influence the fatty acid composition of the skeletal muscle lipids. In an intervention study where middle-aged men were exercising for six weeks, and in a cross-sectional study comparing sedentary with endurance trained young men, it was demonstrated that the fatty acid composition of skeletal muscle lipids differed between physical active and inactive men. In brief, a lower proportion of palmitic acid (16:0) and total n-6 polyunsaturated fatty acids (PUFA) and a higher proportion of stearic (18:0) and oleic acid (18:1n-9) and total n-3 PUFA in the muscle phospholipids were associated with physical activity, despite similar fatty acid composition of the diet. In the second study, that included a larger training volume, differences in the fatty acid profile were also found in the skeletal muscle triglycerides. In contrast, after short-term supra-maximal exercise we found no significant changes in the proportion of the fatty acids in skeletal muscle. Furthermore, after a treatment period of three months, with diets with various dietary fat quality, the proportions of saturated fatty acids (14:0, 15:0 and 17:0) were higher and the proportion of 18:1 n-9 lower in subjects with a high intake of saturated fatty acids compared with subjects with a high intake of monounsaturated fatty acids. In addition subjects given n-3 supplementation had a higher proportion of total n-3 PUFA and lower n-6 PUFA in the skeletal muscle phospholipids than controls. Differences similar to those observed in the phospholipids were found in the triglycerides. In summary, these results suggest that regular aerobic physical activity and dietary fat quality influence the fatty acid composition of the skeletal muscle lipids, which may affect insulin sensitivity and glucose homeostasis.

Numerous diseases are associated with reduced antioxidant defence and oxidative stress. The antioxidant defence includes dietary and endogenous antioxidants and involves complex interactions between them. The effects of dietary factors on antioxidant status and oxidative stress of healthy humans were investigated in the studies described in this thesis. Assays of plasma antioxidant capacity encompass interactions between various antioxidants. Although uric acid has an unclear function as an antioxidant, it is a major determinant of antioxidant capacity. We measured antioxidant capacity in the presence and absence of uric acid to provide more information on the application of measures of antioxidant capacity. Individuals with high dietary intakes of various antioxidants and antioxidant rich foods, especially when combined, had higher plasma antioxidant capacities than those with lower antioxidant intakes. However, there were no associations between dietary intake of antioxidants or antioxidant rich foods and the plasma concentration of F2-isoprostanes, which is considered a reliable biomarker for oxidative stress. Intakes of various doses of a mixture of bilberry juice and black tea, rich in flavonoids for four weeks, increased antioxidant capacity in some groups, but urine levels of F2-isoprostanes were not affected. There were substantial individual variations in responses to the drinks related to baseline antioxidant capacity. Supplementation with eicosapentaenoic acid and docosahexaenoic acid decreased the plasma levels of F2-isoprostanes, but not prostaglandin F2α formation or antioxidant capacity. It was concluded that a high intake of foods rich in antioxidants is related to improved antioxidant status. After intake of foods rich in antioxidants, the antioxidant status may increase, but with considerable individual variation in the responses, which warrants further investigation. Lipid peroxidation in vivo is not easily affected by dietary antioxidants in healthy humans. Although n-3 fatty acids are highly unsaturated, they reduce nonenzymatic free radical-catalyzed lipid peroxidation, but not enzymatic lipid peroxidation.

Η νόσος του Parkinson χαρακτηρίζεται από τη βαθμιαία, εκλεκτική νευροεκφύλιση των ντοπαμινεργικών νευρώνων της μελαινοραβδωτής οδού. Η μειωμένη δραστηριοποίηση των ντοπαμινεργικών υποδοχέων που προκαλείται από την ανεπάρκεια ντοπαμίνης τροποποιεί τη λειτουργία των βασικών γαγγλίων και αναστέλλει τα κινητικά συστήματα. Ιδανικό πειραματικό μοντέλο αποτελεί το μοντέλο weaver, το οποίο εμφανίζει το ίδιο μοτίβο νευροεκφύλισης με τους παρκινσονικούς ασθενείς καθώς και περισσότερη από 70% μείωση της ντοπαμίνης στο ραβδωτό σώμα. Το γεγονός πως δεν υπάρχει σήμερα αποτελεσματική θεραπεία που να σταματά ή να αναστρέφει την εξέλιξη της νόσου, δημιουργεί την ανάγκη ανακάλυψης ενός φαρμακευτικού σχήματος το οποίο θα έχει νευροπροστατευτική δράση και θα περιορίζει τις παρενέργειες. Προηγούμενα αποτελέσματα της ομάδας μας δείχνουν σημαντική επιβίωση των ντοπαμινεργικών κυττάρων στο μοντέλο weaver μετά από χρόνια χορήγηση του ενδογενούς νευροστεροειδούς DHEAS, του χημικού αναλόγου του ΒΝΝ-50 (το οποίο δε μεταβολίζεται σε οιστρογόνα) και του φαρμακευτικού συνδυασμού του ΒΝΝ-50 με τη Ν-ακετυλοκυστεΐνη (NAC), με το τελευταίο να επαναφέρει πλήρως τον αριθμό των κυττάρων στη μέλαινα ουσία. Στην παρούσα εργασία θελήσαμε να διερευνήσουμε τους μηχανισμούς μέσω των οποίων επιτυγχάνεται η νευροπροστασία που προκαλεί η συγχορήγηση του συνδυασμού BNN-50/ΝAC. Για το σκοπό αυτό, αξιολογήσαμε την αντιαποπτωτική, καθώς και την αντιοξειδωτική δράση του σχήματος BNN-50/NAC. Οι δύο δείκτες επιλέχθηκαν λαμβάνοντας υπόψιν τον κεντρικό ρόλο του αποπτωτικού θανάτου στη διαδικασία της νευροεκφύλισης, καθώς και το ρόλο του οξειδωτικού στρες στην παθογένεια της νόσου. Τα αποτελέσματα μας υποδεικνύουν πλειοτροπική δράση του φαρμακευτικού συνδυασμού BNN-50/NAC, η οποία εκφράζεται μέσω της ισχυρής αντιαποπτωτικής και αντιοξειδωτικής του δράσης. / Parkinson 's disease is characterized by the progressive, selective neurodegeneration of the dopaminergic neurons of the nigrostriatal pathway. The decreased activation of dopamine receptors caused by insufficient dopamine levels, modifies the function of the basal ganglia circuit and inhibits the mobility systems. The weaver model consists an ideal model for neuroprotection studies, which exhibits the same pattern of neurodegeneration as the parkinsonian patients and more than 70% decrease of dopamine in the striatum. The fact that there is currently no effective treatment to attenuate or reverse the disease progression, creates the need for discovery of a drug combination which will exhibit neuroprotective effect and reduce the side effects. Previous results of our group, have shown a significant survival of dopaminergic neurons in weaver mice after chronic administration of endogenous neurosteroid DHEA-S, the chemical analog BNN-50 (which is not metabolized to estrogens) and the combination of the BNN-50 with N-acetylcysteine (NAC,with the latter combination completely rescuing the number of dopaminergic cells of the substantia nigra. The aim of this study was to investigate the mechanisms of neuroprotection induced by coadministration of combination BNN-50/NAC. For this purpose, we evaluated the possible antiapoptotic and antioxidant action of the BNN-50/NAC combination. Our results suggest a pleiotropic effect of the BNN-50/NAC drug combination, that is expressed through strong antiapoptotic and antioxidant activity.